Skip to content
OpenCapital
Get started

Avanos Medical AVNS PM&R — Net Sales

Other segment segments

Corporate and other
$1.9M-81.4%

Similar metrics at other companies

Enovis logo
ENOVPrevention & Recovery — Net Sales
$272.02M-0.2%
Enovis logo
ENOVOther Prevention and Recovery — Net Sales
$55.86M-16.2%
Baxter International logo
BAXMedical Products & Therapies — Net Sales
$1.29B+1.8%
Terex logo
TEXMP — Net Sales
$419M+9.7%
XER
XERSProduct revenue, net — Product revenue, net
$82.45M+42.6%
Cytokinetics logo
CYTKNet Product Revenue — Revenue
$4.79M—

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's pm&r — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's PM&R — net sales?
Avanos Medical (AVNS) reported PM&R — net sales of $56.3M in Q1 2026.
How has Avanos Medical's PM&R — net sales changed year-over-year?
Avanos Medical's PM&R — net sales increased by 0.2% year-over-year, from $56.2M to $56.3M.
What is the long-term trend for Avanos Medical's PM&R — net sales?
Over 2 years (2023 to 2025), Avanos Medical's PM&R — net sales has grown at a 2.3% compound annual growth rate (CAGR), from $227.3M to $237.8M.
What does PM&R — net sales mean?
Represents the total revenue generated from the sale of products within the Pain Management and Recovery segment after deductions for returns, allowances, and discounts. This metric serves as a primary indicator of market demand and commercial success for the company's specialized medical device portfolio.